Ally Bridge Group NY LLC Purchases New Position in Avalo Therapeutics, Inc. $AVTX

Ally Bridge Group NY LLC acquired a new position in Avalo Therapeutics, Inc. (NASDAQ: AVTX) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 178,100 shares of the company's stock, valued at approximately $2,264,000. Avalo Therapeutics comprises 1.4% of Ally Bridge Group